Jonathan Seaman joined FairJourney Bio in 2023 and leads UK Discovery & Engineering activities, supporting the development of biotherapeutics for a range of client projects utilising Phage and Mammalian Display techniques. He has worked in the field of Biologics Discovery & Engineering for 17 years. Prior to joining FairJourney Bio, Jon worked at MedImmune/AstraZeneca, leading research projects across multiple therapy areas and helping design novel modalities which have advanced to the clinic. He is a named inventor on five patent families relating to bispecific and multispecific antibodies, as well as more complex fusion molecules.